Žeromskų klinika - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 283,276 | 344,127 | 346,194 | 477,410 | 476,192 | 472,721 | 464,442 | 483,822 |
| Profit before tax | 26,089 | 9,785 | 43,121 | 26,309 | 47,072 | 7,575 | -50,683 | 37,526 |
| Net profit | 22,110 | 8,617 | 33,402 | 22,216 | 45,715 | 5,673 | -50,683 | 30,667 |
| Equity | 65,480 | 74,097 | 57,498 | 79,714 | 60,429 | 66,102 | 15,419 | 46,087 |
| Liabilities | 19,459 | 29,801 | 52,346 | 15,518 | 71,346 | 51,144 | 89,419 | 79,540 |
| Non-current assets | 33,286 | 63,963 | 43,510 | 51,131 | 107,684 | 81,891 | 104,424 | 125,397 |
| Current assets | 51,653 | 39,935 | 66,334 | 44,101 | 24,091 | 35,355 | 414 | 230 |
| Total assets | 84,939 | 103,898 | 109,844 | 95,232 | 131,775 | 117,246 | 104,838 | 125,627 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 60,620 | 52,061 | 49,369 |
| Social insurance contributions | - | - | - | - | - | 58,737 | 50,899 | 48,972 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +15.4% | +21.5% | +0.6% | +37.9% | -0.3% | -0.7% | -1.8% | +4.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 26.0% | 8.3% | 30.4% | 23.3% | 34.7% | 4.8% | -48.3% | 24.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 33.8% | 11.6% | 58.1% | 27.9% | 75.7% | 8.6% | -328.7% | 66.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 7.8% | 2.5% | 9.6% | 4.7% | 9.6% | 1.2% | -10.9% | 6.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 9.2% | 2.8% | 12.5% | 5.5% | 9.9% | 1.6% | -10.9% | 7.8% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.3 | 0.4 | 0.9 | 0.2 | 1.2 | 0.8 | 5.8 | 1.7 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 13,652 | 15,466 | 15,618 | 19,620 | 17,529 | 18,909 | 20,874 | 23,991 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Žeromskų klinika - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-07-16 | 2026-07-17 | 3681.82 |
| 2026-06-17 | 2026-06-17 | 250.95 |
| 2026-06-16 | 2026-06-16 | 383.95 |
| 2026-05-03 | 2026-05-04 | 4.90 |
| 2026-04-24 | 2026-04-29 | 4.90 |
| 2026-04-20 | 2026-04-21 | 3836.88 |
| 2026-03-27 | 2026-03-27 | 396.46 |
| 2026-03-17 | 2026-03-18 | 396.46 |
| 2026-02-24 | 2026-02-24 | 1497.43 |
| 2026-02-18 | 2026-02-23 | 2220.43 |
| 2026-01-20 | 2026-01-20 | 543.77 |
| 2026-01-18 | 2026-01-19 | 1243.77 |
| 2026-01-16 | 2026-01-17 | 1873.77 |
| 2025-12-17 | 2025-12-17 | 1206.30 |
| 2025-12-16 | 2025-12-16 | 4268.30 |
| 2025-11-18 | 2025-11-18 | 1530.53 |
| 2025-10-21 | 2025-10-21 | 216.89 |
| 2025-10-18 | 2025-10-20 | 1436.89 |
| 2025-10-16 | 2025-10-17 | 2025.89 |
| 2025-09-25 | 2025-09-25 | 1048.70 |
| 2025-09-24 | 2025-09-24 | 3423.23 |
| 2025-09-16 | 2025-09-23 | 3544.08 |
| 2025-08-28 | 2025-08-29 | 4289.41 |
| 2025-08-20 | 2025-08-20 | 319.41 |
| 2025-08-19 | 2025-08-19 | 4289.41 |
| 2025-05-23 | 2025-05-25 | 3275.09 |
| 2025-05-17 | 2025-05-22 | 3765.09 |
| 2025-05-16 | 2025-05-16 | 4465.09 |
| 2025-04-30 | 2025-04-30 | 2408.37 |
| 2025-04-24 | 2025-04-27 | 2413.89 |
| 2025-04-19 | 2025-04-23 | 2408.37 |
| 2025-04-18 | 2025-04-18 | 3291.37 |
| 2025-04-16 | 2025-04-17 | 3831.37 |
| 2025-03-22 | 2025-03-24 | 1052.14 |
| 2025-03-19 | 2025-03-21 | 2052.14 |
| 2025-03-18 | 2025-03-18 | 3352.14 |
| 2025-01-17 | 2025-01-19 | 297.56 |
| 2025-01-16 | 2025-01-16 | 1642.56 |
| 2024-11-18 | 2024-11-18 | 1298.26 |
| 2024-02-19 | 2024-02-19 | 1073.32 |
| 2023-11-16 | 2023-11-16 | 1642.22 |
| 2023-09-21 | 2023-09-21 | 145.91 |
| 2023-09-20 | 2023-09-20 | 995.91 |
| 2023-09-18 | 2023-09-19 | 5029.91 |
| 2023-06-20 | 2023-06-20 | 446.51 |
| 2023-06-19 | 2023-06-19 | 936.51 |
| 2023-06-16 | 2023-06-18 | 1796.51 |
| 2023-02-22 | 2023-02-23 | 419.10 |
| 2023-02-21 | 2023-02-21 | 1402.10 |
| 2023-02-17 | 2023-02-20 | 2016.10 |
| 2023-01-24 | 2023-01-24 | 13.81 |
| 2023-01-20 | 2023-01-22 | 13.81 |
| 2022-12-21 | 2022-12-21 | 369.27 |
| 2022-12-19 | 2022-12-20 | 1769.27 |
| 2022-12-16 | 2022-12-18 | 2329.27 |
| 2022-11-21 | 2022-11-22 | 4351.19 |
| 2022-11-17 | 2022-11-18 | 5865.19 |
| 2022-10-28 | 2022-11-16 | 52.38 |
| 2022-09-30 | 2022-10-02 | 1289.23 |
| 2022-09-29 | 2022-09-29 | 3238.28 |
| 2022-09-28 | 2022-09-28 | 4914.58 |
| 2022-09-16 | 2022-09-27 | 5886.35 |
| 2022-09-02 | 2022-09-15 | 37.98 |
| 2022-08-29 | 2022-08-30 | 62.46 |
| 2022-08-23 | 2022-08-28 | 5138.13 |
| 2022-07-18 | 2022-07-20 | 5405.42 |
| 2022-04-19 | 2022-05-08 | 5696.52 |
Žeromskų klinika - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-04-12 | 2026-04-23 | 3.18 |
| 2026-01-08 | 2026-01-16 | 3171.59 |
| 2026-01-05 | 2026-01-07 | 3162.82 |
| 2025-12-15 | 2025-12-18 | 10.81 |
| 2025-11-14 | 2025-11-18 | 6.68 |
| 2025-09-23 | 2025-09-25 | 193.24 |
| 2025-09-19 | 2025-09-22 | 1323.24 |
| 2025-09-16 | 2025-09-18 | 1713.24 |
| 2025-09-13 | 2025-09-15 | 1712.75 |
| 2025-01-22 | 2025-01-22 | 2352.62 |
| 2025-01-15 | 2025-01-21 | 3608.55 |
| 2025-01-10 | 2025-01-14 | 3593.69 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Žeromsku klinika, UAB (code 300110122) is a Private Limited Liability Company engaged in medical specialists activities. In 2025, the company generated revenue of €483.8K, up 4.2% year on year, and returned to profitability with net profit of €30.7K after a loss of €50.7K in 2024. Profit margin improved to 6.3% in 2025 from -10.9% in 2024 and 1.2% in 2023. The 2-3 year revenue trend shows relative stability, moving from €472.7K in 2023 to €464.4K in 2024 and €483.8K in 2025, while profit performance was more volatile. At the end of 2025, total assets were €125.6K, equity €46.1K and liabilities €79.5K. The equity ratio stood at 36.7% and debt to equity at 1.73. Efficiency indicators were strong, with asset turnover at 3.85x, ROE at 66.5% and ROA at 24.4%. Revenue per employee was €24.2K and profit per employee €1.5K.